Dr Cohen, from Cleveland Clinic, discusses his presentation on educating patients with IBD about surgery and working with gastroenterologists to assess if and when surgery is required.
Dr Cohen, from Cleveland Clinic, discusses his presentation on educating patients with IBD about surgery and working with gastroenterologists to assess if and when surgery is required.
IBD Drive Time host Dr Raymond Cross talks with Dr Fernando Velayos from Kaiser Permanente San Francisco Medical Center about monitoring for dysplasia among patients with inflammatory bowel disease.
IBD Drive Time host Dr Raymond Cross talks with Dr Fernando Velayos from Kaiser Permanente San Francisco Medical Center about monitoring for dysplasia among patients with inflammatory bowel disease.
Dr Freddy Caldera from the University of Wisconsin talks to IBD Drive Time host Dr Raymond Cross from the University of Maryland on advising patients with IBD about vaccines for COVID-19, monkeypox, and pneumonia.
Dr Freddy Caldera from the University of Wisconsin talks to IBD Drive Time host Dr Raymond Cross from the University of Maryland on advising patients with IBD about vaccines for COVID-19, monkeypox, and pneumonia.
Dr Kayal recaps the key points of her presentation at AIBD on the treatment of chronic pouchitis among patients who have undergone ileal pouch-anal anastomosis surgery.
Dr Kayal recaps the key points of her presentation at AIBD on the treatment of chronic pouchitis among patients who have undergone ileal pouch-anal anastomosis surgery.
Dr Axelrad recaps his presentation from the Advances in Inflammation Bowel Diseases regional meeting on treating patients with IBD who have a history of cancer or have been diagnosed with a malignancy.
Dr Axelrad recaps his presentation from the Advances in Inflammation Bowel Diseases regional meeting on treating patients with IBD who have a history of cancer or have been diagnosed with a malignancy.
Dr Ha reviews the essential steps to properly diagnosing and treating Clostridiodes difficile among patients with inflammatory bowel disease, which she presented at the AIBD regional meeting.
Dr Ha reviews the essential steps to properly diagnosing and treating Clostridiodes difficile among patients with inflammatory bowel disease, which she presented at the AIBD regional meeting.
Dr Ha reviews the key takeaways from her presentation at the Advances in Inflammatory Bowel Diseases regional meeting on choosing and positioning therapies for ulcerative colitis.
Dr Ha reviews the key takeaways from her presentation at the Advances in Inflammatory Bowel Diseases regional meeting on choosing and positioning therapies for ulcerative colitis.
Dr Axelrad reviews his talk on the use of JAK inhibitors for the treatment of inflammatory bowel diseases which he gave at the AIBD regional meeting September 30.
Dr Axelrad reviews his talk on the use of JAK inhibitors for the treatment of inflammatory bowel diseases which he gave at the AIBD regional meeting September 30.
Dr Kayal discusses her presentation at the AIBD regional meeting on the efficacy and safety of IL-23 inhibitors in the treatment of inflammatory bowel disease.
Dr Kayal discusses her presentation at the AIBD regional meeting on the efficacy and safety of IL-23 inhibitors in the treatment of inflammatory bowel disease.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study.
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...